INOpulse(Bellerophon Pulse Technologie

脉冲式一氧化氮递送系统

Report date: 2025/09/12 20:01:19

Base Information

Drug NameINOpulse(Bellerophon Pulse Technologie
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNitric oxide donors
TargetsNot applicable
Therapy Area/IndicationsRejection of lung transplantationCoronavirus Disease 2019 (COVID-19)Anemia, Sickle Cell +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBellerophon Pulse Technologies Llc
China Registration ClassN/A

Develop Information

Active CompaniesBaylor BioSciencesBellerophonBellerophon Pulse Technologies Llc
Inactive CompaniesMallinckrodtAllegheny Singer Research Institute
Active IndicationsPulmonary FibrosisSarcoidosis, PulmonaryPulmonary Arterial Hypertension +[4] 
Inactive IndicationsRejection of lung transplantationCoronavirus Disease 2019 (COVID-19)Anemia, Sickle Cell +[7] 

Other Information

ATC CodeN/A
Related LinksN/A